UniSuper Management Pty Ltd increased its stake in Xylem Inc. by 57.5% in the fourth quarter, purchasing an additional 71,472 shares, bringing its total holding to 195,848 shares valued at approximately $26.7 million. Xylem reported strong first-quarter results with EPS and revenue exceeding estimates, and raised its FY 2026 guidance. The company also announced a $0.43 quarterly dividend and a new $1.5 billion share repurchase authorization.

Xponance LLC increased its stake in Wells Fargo & Company by 4.4% in the fourth quarter, acquiring an additional 20,967 shares and bringing its total holdings to 502,070 shares valued at approximately $46.8 million. Wells Fargo reported strong Q1 earnings, slightly beating analyst consensus for EPS, and announced a quarterly dividend of $0.45 per share, resulting in an annualized yield of about 2.2%. Despite some recent regulatory concerns, analysts maintain a "Moderate Buy" rating with a consensus price target of $97.53 for the stock.

Stifel reiterated a Buy rating and an $85.00 price target on Cooper Companies (NASDAQ:COO) stock after the company's Q2 fiscal 2026 earnings call. This decision follows Cooper Companies actively pursuing the sale of CooperSurgical and settling a fertility-related case, which analysts believe clears the path for a pure-play CooperVision (contact lens) business. Stifel's analysis suggests an 18% upside from current levels, despite the company lowering its full-year revenue guidance and other firms adjusting price targets due to the planned divestiture.

UniFirst Corporation shareholders have approved the company's acquisition by Cintas Corporation. The deal, valued at $155 in cash and 0.7720 shares of Cintas stock per UniFirst share, garnered approval from over 99% of votes cast. The transaction is anticipated to close in the second half of 2026, subject to customary closing conditions and regulatory approvals.

Baidu's Apollo Go, in partnership with Swiss Post's PostBus, has received a Level 4 driverless operating permit from Switzerland’s Federal Roads Office. This approval allows for hands-free, open-road pilot trials in Eastern Switzerland, with regular fully driverless public transport operations projected to begin by early 2027. This marks Apollo Go's significant expansion into Europe following its substantial growth in autonomous rides globally.

ArrowMark Financial (NASDAQ:BANX) has declared a monthly cash distribution of $0.15 per share for June 2026, maintaining its established payout rate. This decision follows strong first-quarter 2026 earnings, where net investment income of $0.52 per share (or $0.46 per share based on absolute outstanding shares) exceeded the $0.45 quarterly target distribution requirement. The distribution is payable on June 30, 2026, to shareholders of record as of June 23, 2026.

KLA Corporation's stock surged 12% ahead of its 10-for-1 split due to analyst upgrades and strong guidance from CFO Bren Higgins. Higgins highlighted increased visibility into the 2027 wafer fabrication equipment market and significant growth in KLA's advanced packaging process control revenue, projected to reach $1 billion in 2026. The company continues to widen its market share in process control, with aggressive targets for future gains, although potential downside risks include China policy escalation.

Morgan Stanley analysts suggest the Federal Reserve's policy focus is shifting towards "firmer inflation" rather than concerns about "weaker hiring." This change is influenced by recent inflation data, persistent energy price spikes due to the U.S.-Israeli assault on Iran, and a robust labor market. The analysts outline scenarios where inflation could run higher, leading the Fed to maintain or even hike rates.

Maamoun Rajeh has been appointed to lead Arch Capital Group Ltd.'s Insurance, Reinsurance, and Mortgage segments, taking on expanded responsibilities as the company transitions to a single president model. Rajeh, who joined Arch in 2001 and previously built Arch Re into a leading global provider, will now also oversee the Insurance segment. This move follows the departure of David Gansberg, with CEO Nicolas Papadopoulo expressing confidence in Rajeh's deep understanding of the Property and Casualty business.

Gilead Sciences is donating over 2,000 vials of its antiviral therapy, remdesivir, to Uganda to aid in its Ebola Bundibugyo virus disease (BVD) outbreak response. This effort continues Gilead's long-standing commitment to addressing emerging infectious diseases and supporting global health emergencies. The company is also preparing to provide remdesivir and obeldesivir to other regional partners and support clinical trials for Ebola BVD.